Scrip

To Boost Or Not To Boost? Pfizer At Odds With US FDA

Pfizer Unphased By Apparent Pushback

09 Jul 2021

US regulators indicate that authorizing booster shots is not a priority - but Pfizer still plans to seek an EUA in the fall.

US vaccination centre — Despite a rapid uptake from some US adults, so far only 54% have received at least one vaccine dose.

As many countries make plans for possible COVID-19 vaccine booster programs this fall, the US Food and Drug Administration and Centers for Disease Control have pushed back at the suggestion from Pfizer Inc. and BioNTech that the extra shots are necessary in the US – at least for now.

Companies with COVID-19 vaccines such as Pfizer/BioNTech and AstraZeneca have data that they say show a third dose of...